VPC-70619 is a potent, orally active N-Myc inhibitor that disrupts the binding of the N-Myc-Max heterocomplex to DNA E-box elements; it exhibits strong inhibitory activity against N-Myc-dependent cell lines and demonstrates high bioavailability following both oral and intraperitoneal administration.